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I. INTRODUCTION
Genetically modified organisms (GMOs), also known as living
modified organisms (LMOs), could solve many agricultural problems,
such as food shortages and pesticide use.' A "living modified organism"
is defined as "any living organism that possesses a novel combination of
genetic material obtained through the use of modem biotechnology." 2
Scientists can now alter an organism by selecting the genes or traits they
desire, rather than abiding by nature's selection process To date,
biotechnology has already proven itself useful by increasing crop yields
* This Comment was selected as the Best Comment for Spring 2000. To my parents, Rudy
and Nancy Novotny, whose guidance, love, and support, throughout the years helped me achieve
my goals.
1.See Interview by Lauren Thierry and Tony Guida, Hosts of Market Review with Tamnmy
Shea, Environmental Activists, Gateway Green Alliance, and Ryan Utlaut, Bioengineering Farmer,
Utlaut Farms (Feb. 21, 2000); see also Thomas 0. McGarity, InternationalRegulation of
Deliberate Release Biotechnologies, 26 TEX. INT'L L.J. 423, 426 (1991) (discussing
biotechnology's potential benefits).
2. Convention on Biological Diversity, Cartegena Protocol on Biosafety (last modified Oct.
23, 2000) <httpJ/www.biodiv.org>.
3. See McGarity, supranote I, at 426.
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and reducing pesticide use by making plants resistant to pests.4 For
example, soybeans can be given genes from a virus, a soil bacterium and
a petunia to make them resistant to insects; tomatoes can be given fish
genes to delay the process of decomposition.5
However, research on biotechnology has not focused on safety
concerns.' Because of scientific uncertainty as to its effects on the
environment and human health, this technology has come under heated
debate in the international community as to how it should be regulated."
This commentary will examine the unique problems GMOs have created
for the international legal community by looking at the newly drafted
Biosafety Protocol8 and its adequacy in dealing with agricultural
biotechnology. This commentary will also focus on the Protocol's effect
on national regulations and multi-national trade.
II. BACKGROUND
The U.S. Department of Agriculture reports that farmers in the United
States are growing increasing amounts of GMO produce: about one-third
of corn production and fifty percent of soybean production come from
GMO seed." Corn and soybeans are used in many processed foods. For
instance, corn sweeteners are used commonly in sodas, breakfast cereals,
and granola bars.' ° Plus, there is a lot of money invested in GMOs. Even
the United States government has funded some research and development
of GMOs. The government has spent more than US $3.4 billion supporting
these projects."
4. See id.
5. See Marcia Herman-Giddens, Editorial, Beware Foods Produced With "Engineered"
DNA, HERALD-SUN (Durham, N.C.), Feb. 23, 2000, atAl2. Little is known aboutthe shortor longterm effects on people, animals, insects, or the environment. See id
6. See McGarity, supra note 1, at 430.
7. See id. at 434.
8. Convention on Biological Diversity, Cartegena Protocol on Biosafety, supranote 2.
9. See Yoshiaki Sato, Consumer Reaction Hampers GM Food Progress, THE DAILY
YoMIRI (Tokyo), Feb. 24, 2000, at 5, availablein LEXIS, News, by Individual Publication.A
Washington, D.C.-based think tank said that 40% more food would be needed by 2020 because of
projected population growth. See id GM technology might help to meet the demand for more food.
See id.
10. See Alison Arnett, A La Carte; Are You Buying Altered Foods?, BOSTON GLoBE, Feb.
23, 2000, at El. "Soy is not only in tofu products, such as gardenburgers but also in many other
items, from baby formula to many kinds of cooking oils. Id.
11. See Judy Kim, Out of the Lab and Into the Field: Harmonizationof DeliberateRelease
Regulationsfor GeneticallyModified Organisms,16 FORDHAM INT'L L.J. 1160, 1160 (1993). See
generally Lee Egerstrom, Scientists' Debate Over Altered Crops Leaves Many Waiting for
Evidence. ST. PAUL PIONEER PRESS, Feb. 20, 2000, at A4. "Multinational chemical and
pharmaceutical firms have spent more than $100 billion buying and consolidating seed genetics
companies over the past five years in a race to lead the biotechnology revolution. Financial markets
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One problem is that no one knows how the consumption of GMOs may
affect human health. 2 Many producers and suppliers are responding to
public fears that GMOs may adversely affect human health. 3 For example,
Frito-Lay, a giant producer of corn snacks, and Seagram, one of the largest
distillers, told its suppliers that it would not buy GM corn this year.14
Many European consumers want to ban imports of GM crops altogether."
Even though no clear scientific evidence has proven GM crops to be
harmful, farmers are wondering if they will have problems in selling their
GMO harvest to a world concerned
about the consequences to human
16
health and the environment.
To develop this technology, GMOs must be tested in the field, not just
in the laboratory. However, some scientists are concerned that this GMO
field testing may cause environmental problems.'" "Deliberate release" is
the term commonly used for the introduction of GMOs into the
environment. ' Scientists believe that the deliberate release of GMOs is too
environmentally risky and could lead to genetically engineered genes
spreading and recombining out of control. 9 These genes could transfer
their genetically engineered traits to wild relatives and destroy indigenous
species.20 There could be other unexpected consequences. For example,
scientists at Cornell University found that monarch butterflies were dying
after eating milkweed plants, the monarch's favorite food, which were
covered with GMO corn plant pollen.2' The corn plant had originally had
its genes altered to resist pests, but the pollen, which can drift on to other
plants, indiscriminately killed non-targeted insects, too.
Due to these concerns, the United Nations created the Convention on
Biological Diversity during the United Nation's Conference on the
Environment and Diversity (Earth Summit) in Rio De Janeiro in 1992.2
have also embraced biotechnology because of its potential for creating extremely profitable
products." Id
12. See Interview with Tammy Shea, supra note 1.
13. See Arnett, supra note 10, at El.
14. See Julian Borger, US. Farmers Desert GM Crops, THE GUARDIAN, (London) Feb. 17,

2000, at 3. Farmers are responding to public fears by planning to plant sixteen percent less GM corn
than they did last year. See id
15. See Glenn Hess, UN. Countries Sign a Landmark Accord to Regulate Trade in Biotech
Foods, CHEWMICAL MARKET REPORTER, Feb. 7, 2000, at 1.
16. See Borger, supra note 14, at 3.
17. See Kim, supra note 11, at 1160.
18. See id
19. See DAVID HUNTER ET AL., INTERNATIONAL ENwRONMENTAL LAW AND POLICY 997

(David L. Shapiro ed., Foundation Press 1998) (1961).

20. See id
21. See Egerstrom, supra note 11, at A4.
22. See Magen Griffiths, Land and Resource Management: Biosafety Protocol, 1998 COLO.
J.INT'L ENVTL. L. & POL'Y 113, 114. The primary challenge to creating the Protocol's regulations
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This Convention was established to draft a legally binding protocol, which
would regulate transboundary shipment and use of GMOs.23 On January
29, 2000, the members of the Convention finally presented a final draft of
the Biosafety Protocol for ratification.24 The Protocol's goals are to
harmonize international regulations for the deliberate release of GMOs
into the environment, to encourage the development of GMOs, to promote
international trade, and to protect human health and the environment with
common safety standards.25
III. STATUS QUO

The deliberate release of GMOs is currently regulated by individual
governments. 2 In general, nations have produced different types of
regulations for GMOs, such as process-oriented regulations and productspecific regulations." Some countries do not regulate deliberate release of
GMOs at all. There are several advantages and disadvantages to each of
these methods.
Process-oriented regulations view genetic engineering as a risk, and
regulate the process of biotechnology and the end-product.28 For example,
Japan,29 Denmark and Germany have created new laws to deal specifically
with biotechnology.3" Most of these laws include approval procedures that
set safety standards. 3' These laws also provide for civil liability of
manufacturers, and for criminal and civil penalty provisions to promote
enforcement. 32 Even with stringent regulations,
these countries have
33
maintained strong biotechnology industries.
However, there are some drawbacks to process-oriented regulations.
Biotechnology industries in these countries fear for their competitiveness

was that industrialized countries favored the adoption ofvoluntary guidelines; whereas, developing
countries and many nongovernmental organizations wanted a binding biosafety protocol. See id
23. See id at 114. "Genetic engineering allows farmers to use less land to produce more
food." See id at 113.
24. Convention on Biological Diversity, Cartegena Protocol on Biosafety, supra note 2.
25. See id. art. l.
26. See Kim, supranote 11, at 1161-62.
27. See id. at 1170.
28. See id.
29. See idat 1174'
30. See id at 1171-72 (stating that strict measures were adopted in Denmark and Germany.)
In Germany, the strict measures were adopted partly due to pressure from Green Party and other
environmental activists. Id
31. See id at 1173.
32. See James T. O'Reilly, Biotechnology Meets Products Liability: Problems Beyond the
State of the Art, 24 Hous. L. REv. 451,487-89 (1987) (recommending that liability be defined by
statute for drugs and other biotechnology products).
33. See Kim, supranote 11, at 1174.
https://scholarship.law.ufl.edu/fjil/vol13/iss2/4
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in international markets because the laws sometimes slow genetic research

and development.' For instance, the Genetic Technology Law in Germany
includes a provision, which requires public hearings for objections."
These public hearings can significantly delay GMO research. Applying
this provision, a town in Germany had over 16,000 objections, which were
made in response to a company's plans to test GMO petunias in an open
field.36 Thus, these public hearings and strict regulations can have an effect
on the development of GMOs and may dissuade research scientists from
testing GMOs in countries with process-oriented regulations."' These
scientists would most likely go abroad to countries with less severe
restrictions. 3
In contrast, product-specific regulations are less stringent than processoriented regulations because these regulations do not focus on the
techniques used during GMO development, but rather on the use of the
GMO end-product, such as foods or pesticides.39 For instance, the United
States interpreted pre-existing laws to regulate GMOs. 4o In 1986, the
Coordinated Framework for Regulation of Biotechnology was created to
divide the environmental regulation of biotechnology among several
different federal agencies. 4' For example, the EPA regulates the
introduction of GMOs into the environment.42 The FDA reviews the safety
ofGMO food products before marketing is allowed. 43 The USDA regulates

34. See id at 1173.
35. See id The author states: "The German National Parliament passed the process-oriented
Genetic Technology Law in 1990. The Genetic Technology Law permits the release of genetically
'engineered organisms into the environment with the approval of the Federal Health Authority.
('Bundesgesundheitsamt'). Approvals depend upon the safety classification of the deliberate
release." Id. at 1172-73.
36. See id.at 1173. The law reflects the impact of political pressure exerted by public groups.
See id at 1174.
37. See id.
38. See id.at 1173-74.
39. Seeid atl177.
Although several federal agencies now regulate biotechnology, for nearly a
decade, theNational Institutes ofHealth (NIH) assumed primary responsibility for
the safety of genetic engineering. The NIH first developed guidelines for research
involving rDNA in 1976. These guidelines were designed to ensure the safety of
laboratory work and to prevent the accidental escape of rDNA microorganisms.
d at 1178.
40. See id.
41. See Ruth E. Harlow, The EPA and Biotechnology Regulation: Coping with Scientfic
Uncertainly. 95 YALE L.J. 553, 563 (1986) (discussing the current regulations as it applies to
biotechnology).
42. See id at 564.
43. See id
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the agricultural aspects of biotechnology research, such as the release of
GMO plants, animals, and microorganisms."
However, there are some drawbacks to product-specific regulations.
One problem is that three separate agencies have jurisdiction over similar
regulatory provisions which is not very efficient. Some commentators
believe that a centralized agency to regulate biotechnology would improve
efficiency, because then, the agency could focus on biotechnology issues
and become experts in the field.40 The second problem is that the preexisting statutes, which are being used to regulate biotechnology, were
originally created to regulate products unrelated to bioengineered
substances.' These statutes do not regulate GMOs as a potential threat to
the environment and human health.47
In contrast to countries with process-oriented or product-specific
regulations, most developing countries do not have any regulations
pertaining to biotechnology. 48 Because they do not have any regulations,
some developing countries have become test sites for researchers, who are
trying to escape the strict regulations in their own countries.49 This may be
a disadvantage to the developing country because scientists do not know
the effects of GMOs on the environment or human health." However,
some developing countries, such as South Korea and Taiwan, are not
concerned about the possible adverse effects on the environment or health,
and promote the biotechnology industry for the income it generates.51
Thus, they purposefully do not create any regulations. On the other hand,
some countries such as several Latin American, Caribbean,2 and Eastern
European nations are still learning how to regulate GMOs.
Because individual governments have different methods of regulating
GMOs, it is difficult to set up a system for international trade. 3 It is hard
to know what one country requires and what another does not. In sum, an

44. See Gary Marchant, ModifiedRulesforModified Bugs: BalancingSafety andEfficiency
in the Regulation of DeliberateRelease of GeneticallyEngineeredMicroorganisms, I HARV. J.L.
& TECH. 163, 170 (1988) (discussing dissatisfaction with the U.S. regulatory scheme for

biotechnology).
45.
46.
47.
48.
49.
50.
51.

See Harlow, supra note 41, at 555.
See Kim, supra note 11, at 1178.
See id at 1180.
See HUNTER et al., supra note 19, at 997.
SeeKim, supranote 11, at 1184.
See HUNTEit et al., supra note 19, at 997.
See Peter Newmark, Pacific Rim Tactic: U.S. PartnersNow, Worldwide Bio-Markets

Later, BIOTECHNOLOGY NEWSWATCH, Sept 19, 1988, at 7.

52. See Kim, supra note 11, at 1183.
53. See McGarity, supra note 1, at 437.
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international agreement to harmonize the various nations' regulations
is
54
needed to help facilitate trade and to protect the environment.
IV.

ANALYSIS

On January 29, 2000, the Biosafety Protocol was finally drafted and
sent for ratification after five years of talks" by the members of the
Convention on Biological Diversity, a part of the United Nations. 6 More
than 130 countries participated in the Convention." However, the United
States is not a party to the Convention or the Biosafety Protocol, because
the United States favors voluntary guidelines.5" The objectives of the
Biosafety Protocol are to ensure the safe transfer, handling, and use of
GMOs during transboundary59 transport, because GMOs may have adverse
effects on human health and the environment. 6° Basically, the Protocol
focuses on the protection of the environment by regulating the deliberate
release of GMOs, yet promotes trade by requiring scientific evidence to
support the more protective regulations.
A. Basic Provisions
For an overview, the Biosafety Protocol requires several procedures to
be completed before any GMO products may be shipped. The Protocol
requires notification, advance informed consent, and documentation for
each shipment containing GMOs. 6' These procedures only relate to
transboundary shipments.62 Countries may still have different internal
regulations.63

54. See Kim, supra note 11, at 1185.
55. Convention on Biological Diversity, Cartegena Protocol on Biosafety, supra note 2.
56. See Griffiths, supra note 22, at 114.
57. CautionNeeded, THEEcONOMISTNEWSPAPER, LTD., Feb. 5,2000, at 5. The concern over

potential health risks has prompted the EU to ban certain foods containing GMOs, such as beef that
contains hormones or meat from livestock fed with genetically-altered feed. See id.
58. See Griffiths, supra note 22, at 117.
59. Convention on Biological Diversity, Cartagena Protocol on Biosafety, supranote 2, art.
3(k). Article 3(k) defines "transboundary movement" as the "movement of a living modified
organism from one Party to another Party," which also extends to movement between Parties and
non-Parties. Id
60. See id.art. 4. This Protocol does not cover "contained use" of GMOs. In Article 3(b),
"contained use means any operation, undertaken within a facility, installation or other physical
structure, which involves living modified organisms that are controlled by specific measures that
effectively limit their contact with.., the external environment." Id
61. See id. arts. 7-9.
62. See id
63. See id. Article 11, paragraph 4 states that a "[plarty may take a decision on the import of
living modified organisms intended... under its domestic regulatory framework that is consistent
with the objective of this Protocol." Id
Published by UF Law Scholarship Repository, 2001
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First, there are several procedures to follow before an exporter can ship
its GMO products. The notification provision in Article 8" requires an
exporter to send information to the importer, stating that the exporter
wants to ship its GMO products to their country, and that it will send all
the information about the product required by Annex .65
Next, the importer must tell the exporter it has received the
notification." Then, the importing country is given 270 days to study the
information and to decide whether to accept the GMO products based on
risk assessments and scientific evidence. 7 This is known as advance
informed consent.6 To decide whether to accept a GMO product, an
importer may use their own existing regulations.69 Developing countries
who do not have regulations are given extra time to study risk assessments
and are given the opportunity to ask for more information.7" Article 7
specifies that an advance informed agreement shall apply prior to the first
intentional transboundary movement of GMOs. 7' Therefore, the advance
informed agreement only applies to the first shipment of GMO intended
for release in the environment, instead of each shipment?2
Even though these provisions would help ensure the safe release of
GMOs, there are several problems with these procedures. First, countries
who do not have regulations73 in place will have to spend a lot of time and
money to completely change their shipping system to comply. Second, the
advance informed consent procedure74 gives the importing country a lot of
64. See id art. 8.
65. See id annex 1. Annex I lists the information required in notifications under Articles 8,
10, and 13. See id
66. See id art. 9.
67. See id art. 10. Article 10 pertains to the procedure for deciding whether to accept a GMO
export. See id
68. See id art. 7. Article 7 pertains to the application of the advance informed agreement

procedure. See id.
69. See id art. 14. Article 14 states that any Party may determine that its domestic regulations
shall apply with respect to specific imports to it. See id.
70. See id art. 11. Article 1 states that a

developing country Party, in the absence of domestic regulatory framework,
declare through the Biosafety Clearing-House that its decision prior to the first
import of a GMO, according to a) a risk assessment; and b) a decision made
within a predictable timeframe, not exceeding two hundred and seventy days.
However, if the Party does not communicate its decisions within the timeframe,
it will not imply its consent, unless otherwise specified by the Party.

Id
71.
72.
73.
74.

See id art. 7.
See Id
See Kim, supra note 11, at 1170.
Convention on Biological Diversity, Cartegena Protocol on Biosafety, supra note 2.
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time to study the risk assessments," which may be considered a trade
restriction. Third, even though the members to the Convention say the
Protocol is legally binding,76 it may be hard to enforce. Several countries,
such as the United States, are not parties to the Protocol and are not
obliged to follow the Protocol."
B. EnvironmentalProvisions
The GMOs used for release into the environment, such as OMO seeds,
are regulated stringently. Article 18 paragraph 2(c) specifies that for
transboundary movements containing GMOs that will be released into the
environment, "each Party shall take necessary measures to require that the
GMOs are handled, packaged and transported under conditions of safety,
taking into consideration relevant international rules and standards." '
Article 18(3) also states that at the next meeting of the members, the
drafters will try to develop specific standards for handling, packaging, and
transporting GMOs.7
The problem with this provision is that it applies too many vague
conditions. First, the phrase "handled, packaged and transported under
conditions of safety ' does not explain how these GMOs should be sent.
Perhaps once Article 18(3) is completed, it will be apparent how to
interpret these phrases. Second, the phrase "taking into consideration
relevant international rules"'" implies that the GMOs should be shipped
according to international standards. The problem is that these standards
are not yet constructed.
C. Health Provisions
The GMOs used for food, feed, or processing are not as strictly
regulated. Article 18 paragraph 2(a) requires documentation to accompany
GMOs intended for use as food, feed, or processing, that clearly identifies
that they "may contain" GMOs and are not intended for the intentional
introduction into the environment.8 2

75. See id art. 15. Article 15 pertains to risk assessments. See id Annex III states that the
objective of a risk assessment is to identify and evaluate the potential adverse effects of GMOs in
the potential receiving environment See id.
76. See Griffiths, supra note 22, at I11.
77. See id. at l6.
78. Convention on Biological Diversity, Cartegena Protocol on Biosafety, supranote 2.
79. See id art. 18.
80. See id

81. See id
82. See id Article 18 outlines the procedure for GMOs intended for direct use as food, feed,

or processing. See id
Published by UF Law Scholarship Repository, 2001

9

JOURNAL OF INTERNATIONAL LAW
Florida Journal ofFLORIDA
International
Law, Vol. 13, Iss. 2 [2001], Art. 4

(Vol. 13

This provision may be beneficial for product-specific countries, 3 like
the United States, because the documentation only specifies that the
shipment "may contain" GMO products.' For example, farmers in the
United States currently mix GMO food with conventional varieties."5 It
would be very expensive and time-consuming to separate all these
shipments." However, farmers may want to separate GMO food if
process-oriented countries, such as the European Community, will not buy
it."
D. Trade Provisions

To help facilitate trade, Article 20 tries to unify these new international
regulations by creating an internet-based Biosafety Clearing-House." The
Clearing-House will facilitate the "exchange of scientific, technical,
environmental and legal information on GMOs; and assist parties to
implement the Protocol."' 9 This Biosafety Clearing-House will help
facilitate trade by providing countries access to information on other
countries' laws, advance informed agreements, import decisions, multinational agreements, and prior risk assessments for GMOs. °
The main problem with this provision is the massive amounts of
paperwork it will continually generate. It will also take a long time to
initially set up this system. If the Clearing-House49' will keep track of all
GMO-related documents for over 130 parties,' it may soon become
overloaded with information. Yet, if the Clearing-House93 is prepared to
meet this burden, the information would be very helpful in unifying the
current system.
V. CONCLUSION

International guidelines are needed to help regulate the trade of GMOs
between countries, while also providing for the protection of the

83. Kim, supranote 11, at 1177.
84. Convention on Biological Diversity, Cartegena Protocol on Biosafety, supra note 2, art.
11.
85.
86.
87.
88.

See Fred Pearce, Let Battle Commence, NEw SCEnST, Feb. 6, 2000, at 5.
See id.
See id
Convention on Biological Diversity, Cartegena Protocol on Biosafety, supra note 2, art.

20.
89. Id.
90. See id

91. See id.
92. CautionNeeded, supranote 57.
93. Convention on Biological Diversity, Cartegena Protocol on Biosafety, supra note 2.
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environment and health." Currently, the existing regulations are not

unified and most do not provide for the safe deliberate release of GMOs
into the environment." Plus, scientists do not yet know the effects GMOs
will have on human health or the environment." The Biosafety Protocol
may finally provide some guidance for countries to regulate GMOs. The
Protocol's framework provides for some protective measures for the
environment, while still allowing trade.
However, if trade interests continue to rule over environmental and
human health interests, the potential adverse effects could be costly.9"
There needs to be more scientific tests concerning safety. The law has
lagged behind technology long enough. The international legal and
scientific communities must combine their efforts to adequately address
this problem and promote the safe use of GMOs until more is known about
them.

94. See McGarity, supra note 1, at 434.
95. See id
96. See JULIE HILL, INTERPRETING THE PRECAUTIONARY PRINCIPLE 174 (James Cameron &

Timothy O'Riordan eds., Earthscan) (1994).
97. See McGarity, supranote 1, at 430.
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